Compare AU

Compare ITEK vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

iShares Future Tech Innovators ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares Future Tech Innovators ETF (ITEK) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

ITEK

DRUG

Popularity

Low

Low

Pearlers invested

2

63

Median incremental investment

$2,500.00

$990.50

Median investment frequency

Fortnightly

Monthly

Median total investment

$5,521.88

$1,910.37

Average age group

> 35

26 - 35


Key Summary

ITEK

DRUG

Strategy

ITEK.AX was created on 2022-08-15 by iShares. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with the performance of the equally weighted return of the various indices of the Underlying Funds in which the Fund invests, before fees and expenses

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

iShares Digitalisation ETF USD Acc (17.07 %)

iShares Global Clean Energy ETF (16.94 %)

iShares Automation&Robotics ETF USD Dist (16.75 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (99.97 %)

Communication Services (0.00 %)

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (53.40 %)

Japan (7.60 %)

China (4.56 %)

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.63 %

0.57 %


Key Summary

ITEK

DRUG

Issuer

iShares

BetaShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.63 %

0.57 %

Price

$29.45

$8.27

Size

$5.613 million

$182.401 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

0.08 %

1.90 %

Market

ASX

ASX

First listed date

16/08/2022

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

ITEK

DRUG

Popularity

Low

Low

Pearlers invested

2

63

Median incremental investment

$2,500.00

$990.50

Median investment frequency

Fortnightly

Monthly

Median total investment

$5,521.88

$1,910.37

Average age group

> 35

26 - 35


Pros and Cons

ITEK

DRUG

Pros

  • Higher exposure to AU market

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to AU market

ITEK

DRUG

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home